Effect of gilteritinib on survival in patients with FLT3-mutated (FLT3(mut+)) relapsed/refractory (R/R) AML who have common AML co-mutations or a high FLT3-ITD allelic ratio Meeting Abstract
| Authors: | Levis, M. J.; Perl, A. E.; Martinelli, G.; Cortes, J. E.; Neubauer, A.; Berman, E.; Montesinos, P.; Baer, M. R.; Larson, R. A.; Chou, W. C.; Yokoyama, H.; Recher, C.; Yoon, S. S.; Hill, J. E.; Rosales, M.; Liu, C.; Bahceci, E. |
| Abstract Title: | Effect of gilteritinib on survival in patients with FLT3-mutated (FLT3(mut+)) relapsed/refractory (R/R) AML who have common AML co-mutations or a high FLT3-ITD allelic ratio |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 406s |
| Language: | English |
| ACCESSION: | WOS:000487345806203 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.7000 |
| Notes: | Meeting Abstract: 7000 -- Source: Wos |
